Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dziedzic

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|November 26, 2022
Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients TreatmentAngela Dziedzic, Joanna Saluk
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|November 10, 2018
Interactions between platelets and leukocytes in pathogenesis of multiple sclerosisAngela Dziedzic, Michał Bijak
Frontiers in Molecular Neuroscience|June 19, 2023
Remyelination in multiple sclerosis from the miRNA perspectiveKarina Maciak, Angela Dziedzic, Joanna Saluk
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 2, 2022
Possible role of the NLRP3 inflammasome and the gut-brain axis in multiple sclerosis-related depressionKarina Maciak, Angela Dziedzic, Joanna Saluk
Cells|February 6, 2019
Pro-Thrombotic Activity of Blood Platelets in Multiple SclerosisJoanna Saluk-Bijak, Angela Dziedzic, Michal Bijak
International Journal of Biological Macromolecules|August 27, 2017
Flavonolignans reduce the response of blood platelet to collagenMichal Bijak, Angela Dziedzic, Joanna Saluk-Bijak
Molecules (Basel, Switzerland)|February 15, 2018
Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood PlateletsMichal Bijak, Rafal Szelenberger, Angela Dziedzic, et al.
International Journal of Molecular Sciences|March 19, 2020
The GPR17 Receptor-A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple SclerosisAngela Dziedzic, Elzbieta Miller, Joanna Saluk-Bijak, et al.
International Journal of Molecular Sciences|August 23, 2020
Metformin as a Potential Agent in the Treatment of Multiple SclerosisAngela Dziedzic, Joanna Saluk-Bijak, Elzbieta Miller, et al.
International Journal of Molecular Sciences|April 30, 2021
miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A ReviewKarina Maciak, Angela Dziedzic, Elzbieta Miller, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|November 26, 2022
Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients TreatmentAngela Dziedzic, Joanna Saluk
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|November 10, 2018
Interactions between platelets and leukocytes in pathogenesis of multiple sclerosisAngela Dziedzic, Michał Bijak
Frontiers in Molecular Neuroscience|June 19, 2023
Remyelination in multiple sclerosis from the miRNA perspectiveKarina Maciak, Angela Dziedzic, Joanna Saluk
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 2, 2022
Possible role of the NLRP3 inflammasome and the gut-brain axis in multiple sclerosis-related depressionKarina Maciak, Angela Dziedzic, Joanna Saluk
Cells|February 6, 2019
Pro-Thrombotic Activity of Blood Platelets in Multiple SclerosisJoanna Saluk-Bijak, Angela Dziedzic, Michal Bijak
International Journal of Biological Macromolecules|August 27, 2017
Flavonolignans reduce the response of blood platelet to collagenMichal Bijak, Angela Dziedzic, Joanna Saluk-Bijak
Molecules (Basel, Switzerland)|February 15, 2018
Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood PlateletsMichal Bijak, Rafal Szelenberger, Angela Dziedzic, et al.
International Journal of Molecular Sciences|March 19, 2020
The GPR17 Receptor-A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple SclerosisAngela Dziedzic, Elzbieta Miller, Joanna Saluk-Bijak, et al.
International Journal of Molecular Sciences|August 23, 2020
Metformin as a Potential Agent in the Treatment of Multiple SclerosisAngela Dziedzic, Joanna Saluk-Bijak, Elzbieta Miller, et al.
International Journal of Molecular Sciences|April 30, 2021
miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A ReviewKarina Maciak, Angela Dziedzic, Elzbieta Miller, et al.
Pageof 4